Your browser doesn't support javascript.
loading
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus.
Bae, Jaehyun; Park, Taegyun; Kim, Hyeyoung; Lee, Minyoung; Cha, Bong-Soo.
Afiliação
  • Bae J; Division of Endocrinology and Metabolism, Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.
  • Park T; Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea.
  • Kim H; Medical information and Pharmacovigilance Team, CKD Pharmaceutical Corp., Seoul, Korea.
  • Lee M; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Cha BS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Diabetes Metab J ; 45(3): 326-336, 2021 05.
Article em En | MEDLINE | ID: mdl-33866775
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiazolidinedionas / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Revista: Diabetes Metab J Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiazolidinedionas / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Revista: Diabetes Metab J Ano de publicação: 2021 Tipo de documento: Article